Evaluation of angiotensin converting enzyme 2

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly contagious virus that uses angiotensin converting enzyme 2 (ACE2), a pivotal member of the renin-angiotensin system (RAS), as its cell-entry receptor. Another member of the RAS, angiotensin II (Ang II), is the major biologicall...

Full description

Saved in:
Bibliographic Details
Published inBMC infectious diseases Vol. 24; no. 1
Main Authors Kakavandi, Ehsan, Sadeghi, Kaveh, Shayestehpour, Mohammad, Mirhendi, Hossein, Rahimi Foroushani, Abbas, Mokhtari-Azad, Talat, Shafiei Jandaghi, Nazanin Zahra, Yavarian, Jila
Format Journal Article
LanguageEnglish
Published BioMed Central Ltd 22.04.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly contagious virus that uses angiotensin converting enzyme 2 (ACE2), a pivotal member of the renin-angiotensin system (RAS), as its cell-entry receptor. Another member of the RAS, angiotensin II (Ang II), is the major biologically active component in this system. There is growing evidence suggesting that serum miRNAs could serve as prognostic biomarkers for SARS-CoV-2 infection and regulate ACE2 expression. Therefore, the aim of this study is to evaluate the changes in the serum levels of sACE2 and Ang II, as well as the expression level of miR-141-3p and miR-421 in SARS-CoV-2 positive and negative subjects. In the present study, the serum levels of sACE2 and Ang II were measured in 94 SARS-CoV-2 positive patients and 94 SARS-CoV-2 negative subjects with some symptoms similar to those of SARS-CoV-2 positive patients using the ELISA method. In addition, the expression level of miR-141-3p and miR-421 as ACE2 regulators and biomarkers was evaluated using quantitative real-time PCR (qRT-PCR) method. The mean serum sACE2 concentration in the SARS-CoV-2-positive group was 3.268 [+ or -] 0.410 ng/ml, whereas in the SARS-CoV-2 negative group, it was 3.564 [+ or -] 0.437 ng/ml. Additionally, the mean serum Ang II level in the SARS-CoV-2 positive and negative groups were 60.67 [+ or -] 6.192 ng/L and 67.97 [+ or -] 6.837 ng/L, respectively. However, there was no significant difference in the serum levels of sACE2 (P value: 0.516) and Ang II (P value: 0.134) between the SARS-CoV-2 positive and negative groups. Meanwhile, our findings indicated that the expression levels of miR-141-3p and miR-421 in SARS-CoV-2 positive group were significantly lower and higher than SARS-CoV-2 negative group, respectively (P value < 0.001). Taken together, the results of this study showed that the serum levels of sACE2 and Ang II in SARS-CoV-2 positive and negative subjects were not significantly different, but the expression levels of miR-141-3p and miR-421 were altered in SARS-CoV-2 positive patients which need more investigation to be used as biomarkers for COVID-19 diagnosis.
AbstractList Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly contagious virus that uses angiotensin converting enzyme 2 (ACE2), a pivotal member of the renin-angiotensin system (RAS), as its cell-entry receptor. Another member of the RAS, angiotensin II (Ang II), is the major biologically active component in this system. There is growing evidence suggesting that serum miRNAs could serve as prognostic biomarkers for SARS-CoV-2 infection and regulate ACE2 expression. Therefore, the aim of this study is to evaluate the changes in the serum levels of sACE2 and Ang II, as well as the expression level of miR-141-3p and miR-421 in SARS-CoV-2 positive and negative subjects. In the present study, the serum levels of sACE2 and Ang II were measured in 94 SARS-CoV-2 positive patients and 94 SARS-CoV-2 negative subjects with some symptoms similar to those of SARS-CoV-2 positive patients using the ELISA method. In addition, the expression level of miR-141-3p and miR-421 as ACE2 regulators and biomarkers was evaluated using quantitative real-time PCR (qRT-PCR) method. The mean serum sACE2 concentration in the SARS-CoV-2-positive group was 3.268 [+ or -] 0.410 ng/ml, whereas in the SARS-CoV-2 negative group, it was 3.564 [+ or -] 0.437 ng/ml. Additionally, the mean serum Ang II level in the SARS-CoV-2 positive and negative groups were 60.67 [+ or -] 6.192 ng/L and 67.97 [+ or -] 6.837 ng/L, respectively. However, there was no significant difference in the serum levels of sACE2 (P value: 0.516) and Ang II (P value: 0.134) between the SARS-CoV-2 positive and negative groups. Meanwhile, our findings indicated that the expression levels of miR-141-3p and miR-421 in SARS-CoV-2 positive group were significantly lower and higher than SARS-CoV-2 negative group, respectively (P value < 0.001). Taken together, the results of this study showed that the serum levels of sACE2 and Ang II in SARS-CoV-2 positive and negative subjects were not significantly different, but the expression levels of miR-141-3p and miR-421 were altered in SARS-CoV-2 positive patients which need more investigation to be used as biomarkers for COVID-19 diagnosis.
Audience Academic
Author Rahimi Foroushani, Abbas
Shafiei Jandaghi, Nazanin Zahra
Yavarian, Jila
Mokhtari-Azad, Talat
Shayestehpour, Mohammad
Sadeghi, Kaveh
Mirhendi, Hossein
Kakavandi, Ehsan
Author_xml – sequence: 1
  fullname: Kakavandi, Ehsan
– sequence: 2
  fullname: Sadeghi, Kaveh
– sequence: 3
  fullname: Shayestehpour, Mohammad
– sequence: 4
  fullname: Mirhendi, Hossein
– sequence: 5
  fullname: Rahimi Foroushani, Abbas
– sequence: 6
  fullname: Mokhtari-Azad, Talat
– sequence: 7
  fullname: Shafiei Jandaghi, Nazanin Zahra
– sequence: 8
  fullname: Yavarian, Jila
BookMark eNqFjkFLw0AQRhepYFv9A55y9bA6s5PM7h5LqbZQKFjxGrbJJETqBty0qL_egh568_R9h8fjTdQo9lGUukW4R3T8kNA46zWYXIMnBE0Xaoy5RW2I8tHZv1KTlN4A0Drjx0ovjmF_CEPXx6xvshDbrh8kpi5mVR-P8jF0sc0kfn-9S2au1WUT9klu_naqto-Ll_lSrzdPq_lsrVt2rAsmroumCvWuDp4YaobcGXRAnHvy7BpXFGCZxCBwxRaoksIjS1OZHU3V3a-1DXspu3gKGeRzaMMhpXK1fS5n1uOpHz3_w25ez9kfInlUkg
ContentType Journal Article
Copyright COPYRIGHT 2024 BioMed Central Ltd.
Copyright_xml – notice: COPYRIGHT 2024 BioMed Central Ltd.
DBID IOV
ISR
DOI 10.1186/s12879-024-09310-3
DatabaseName Gale In Context: Opposing Viewpoints
Science in Context
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-2334
ExternalDocumentID A791178196
GeographicLocations Iran
GeographicLocations_xml – name: Iran
GroupedDBID ---
0R~
23N
2WC
53G
5VS
6J9
6PF
7X7
88E
8C1
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
IOV
ISR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
ID FETCH-LOGICAL-g686-5636d5fcadbda9360d6048218036493968f8550763e2106c6703ce5916efc2b3
IEDL.DBID M48
ISSN 1471-2334
IngestDate Fri Jun 27 05:43:18 EDT 2025
Fri Jun 27 06:12:44 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-g686-5636d5fcadbda9360d6048218036493968f8550763e2106c6703ce5916efc2b3
ParticipantIDs gale_incontextgauss_ISR_A791178196
gale_incontextgauss_IOV_A791178196
PublicationCentury 2000
PublicationDate 20240422
PublicationDateYYYYMMDD 2024-04-22
PublicationDate_xml – month: 04
  year: 2024
  text: 20240422
  day: 22
PublicationDecade 2020
PublicationTitle BMC infectious diseases
PublicationYear 2024
Publisher BioMed Central Ltd
Publisher_xml – name: BioMed Central Ltd
SSID ssj0017829
Score 2.389362
Snippet Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly contagious virus that uses angiotensin converting enzyme 2 (ACE2), a pivotal member of...
SourceID gale
SourceType Aggregation Database
SubjectTerms Analysis
Angiotensin converting enzyme
Biological markers
MicroRNA
Title Evaluation of angiotensin converting enzyme 2
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dS8MwEA9zgvgifuLnKOJrdG3aS_MgMmVjClPYnAxfRtMmRdAM1w2cf72X2OkeJvhSQgkHyXH3y4_7IuSM-0IjO45pmumEIt8QVCJM4AqxJRAhKGWLkzv30O6Hd4NoUCHzcUflBRZLqZ2dJ9Ufv55_vM-u0OAvncHHcFGgj-WCItpQ5OfWr6yQVUQmbicadMLfqAKioXDVRtynAWPhvIhmqYzSRy-gTWuTbJTPRK_xrdctUlFmm6x1ykD4DqHNny7d3kh7iclfRi4X3Xguj9z2Bsg9ZT5nb8oLdkmv1Xy8adNy8gHNIQYaAYMs0mmSySwRDOoZoKEhGNugoWACYu36kAFTyNggBTRbW07lg9JpINkeqZqRUfvEQylRHf_EXCnUg5YCLTiLIuknXMuQH5BTe8ih7QRhbKpJnkyLYnj78DRscPSDHB8M8NemXndh0-F_JB2R9cBdcUiD4JhUJ-OpOkFQn8iaI8M1py_8dq-fvwBhTpxq
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+angiotensin+converting+enzyme+2&rft.jtitle=BMC+infectious+diseases&rft.au=Kakavandi%2C+Ehsan&rft.au=Sadeghi%2C+Kaveh&rft.au=Shayestehpour%2C+Mohammad&rft.au=Mirhendi%2C+Hossein&rft.date=2024-04-22&rft.pub=BioMed+Central+Ltd&rft.issn=1471-2334&rft.eissn=1471-2334&rft.volume=24&rft.issue=1&rft_id=info:doi/10.1186%2Fs12879-024-09310-3&rft.externalDBID=IOV&rft.externalDocID=A791178196
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2334&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2334&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2334&client=summon